Delivery Order SPE2DB24D9144-SPE2DB25FCMNH

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,556.80 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML. This delivery order is part of a larger indefinite delivery contract, SPE2DB, valued up to $4,999,999 through 2025, that allows DLA to issue delivery orders for a broad range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PEDVAXHIB vaccine vials, 0.5 milliliters each, with a ceiling value of $1,792.53 and a performance period ending on April 24, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific program. DMS Pharmaceutical Group holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The order is for the PEDVAXHIB vaccine in 0.5mL vials, with a potential value of $1,751.40 and a completion date of February 23, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract, SPE2DB, with DLA valued at up to $4,999,999 through 2025, which enables DLA to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division of the Department of Defense. The $1,282.40 order is for the supply of PEDVAXHIB 0.5ML 10S, a pharmaceutical product, with a period of performance through May 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,784.00 firm fixed-price contract is to provide the PEDVAXHIB vaccine in 0.5 ml vials to fulfill the recurring pharmaceutical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,502.80 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials, with a performance period ending on July 31, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program. The IDC...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the PEDVAXHIB vaccine in 0.5 mL vials. The delivery order has a potential value of $1,190.58 and a completion date of February 21, 2024. This delivery order is part of DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with the Defense Logistics Agency, valued up to $4,999,999 through 2025, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PEDVAXHIB vaccine vials, with a potential value of $1,167.60 and a completion date of February 16, 2024. The contract is not designated as a set-aside. It is issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDV)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PEDVAXHIB vaccine vials in 0.5 ml doses, with a ceiling value of $5,838.00 and an ultimate completion date of August 15, 2024. The contract is not set-aside and is part of a larger indefinite delivery contract (IDC) vehicle held by DMS...
This federal contract award, with ID SPE2DB20D9135|SPE2DB24FZW58, is for the delivery of the PEDVAXHIB vaccine vial (0.5ml) to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,784.00 and is a firm fixed-price delivery order, with no set-aside designation. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB25FCMNH
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of PEDVAXHIB VACCINE VIAL 0.5ML, valued at $1,593.36, with a performance period through March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This contract award is not associated with any set-aside designation.

Generated 6/24/25, 9:58 AM